Top compounds associated with response to CNTLN


Feature Type Standardized
Nominal ANOVA
mRNA ML239 CTRPv2 pan-cancer AAC 0.18 8e-07
mRNA BX-912 GDSC1000 pan-cancer AAC 0.14 2e-06
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.14 4e-06
mRNA FK866 GDSC1000 pan-cancer AAC 0.14 4e-06
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.15 4e-06
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC 0.16 5e-06
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 7e-06
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC 0.13 1e-05
mRNA ZG-10 GDSC1000 pan-cancer AAC 0.2 1e-05
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 3e-05
Download CSV